Singapore Biotech and Life Sciences Patent Services
Life Sciences Patent Attorneys in Singapore
Cantab IP is a Singapore-based patent firm advising on biotechnology, pharmaceutical and life sciences inventions. We help local and international clients protect biotech, pharma, medtech, diagnostics and healthcare technologies through Singapore patent drafting, filing, prosecution and related IP advice.
Singapore Biotech, Pharma and Life Sciences Patent Attorney
Our principal attorney, Dr Khoo Chong-Yee, has more than 30 years of experience as a biotech, pharma and life sciences patent attorney, having worked in the United Kingdom, Europe and Singapore. He is one of the few technically qualified biotech patent attorneys in Singapore and Southeast Asia with a Ph.D. in DNA replication and the cell cycle.
Dr Khoo has substantial experience in patent drafting, prosecution and defence across biotechnology, pharmaceuticals, diagnostics, medtech, healthcare and related life sciences fields. His clients include universities, research institutions, biotech startups, SMEs and large pharmaceutical companies in Singapore, Asia, Europe and the United States.
Dr Khoo holds a Ph.D. from Cambridge University in DNA replication and the cell cycle and has published research in Nature and Current Biology. Prior to founding Cantab IP, he was a partner in the biotechnology and life sciences group at one of the leading patent and trade mark firms in the UK. He also has industry experience from his time working in-house in the IP department of a major Danish diagnostics manufacturer.
Dr Khoo has represented a range of prominent organisations in the fields of food sciences, vaccines, pharmaceuticals, and numerous prestigious universities and research institutes globally. He enjoys engaging with inventors on scientific matters and has had the privilege of working alongside several Nobel Prize winners.
Biotechnology, Pharmaceutical and Life Sciences IP Experience
Cantab IP advises on Singapore patent and IP issues across a broad range of biotechnology, pharmaceutical, medtech and life sciences technologies, including:
- Diagnostics and personalised medicine
- Drug screening
- Oncology and cancer biology (e.g., breast cancer, liver cancer)
- Tumour therapy and CAR T-cell therapy
- Drug delivery
- Microarray technologies
- Genes, proteins, nucleic acids and polypeptide sequences
- Cell cycle, zinc fingers, GPCRs
- Gene editing and CRISPR
- Cell lines and cell culture
- Embryonic stem cells (ES cells)
- Developmental biology
- Antibody technology
- Vaccines
- Tropical diseases (e.g., dengue, chikungunya)
- Bioinformatics
- Pharmaceutical inventions, including combination therapies
- Food technology
- Medical equipment
- Medical technology (medtech)
- Personalised medicine
- Artificial intelligence (AI) and machine learning (ML)
We act for local and international funding agencies, research institutes, universities, SMEs, biotech startups and pharmaceutical companies seeking Singapore life sciences patent and IP advice.
Singapore Patent Term Extensions for Pharmaceutical Products
Under Singapore patent law, extensions of term may be available where there has been delay in obtaining marketing approval for pharmaceutical products. These extensions are relevant to Singapore pharma patent strategy and are broadly comparable to Supplementary Protection Certificates (SPCs) in Europe.
For further details, please refer to our article on patent term extensions in Singapore.
Regulatory IP and Life Sciences Commercialisation
Cantab IP also advises on IP issues arising from the regulatory approval process under the Singapore Medicines Act, including issues relevant to pharmaceutical products, diagnostics, medtech and healthcare technologies. We also advise on Plant Variety Rights and related life sciences IP matters.